FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2005124425> ?p ?o ?g. }

• W2005124425 endingPage "1524" @default.
• W2005124425 startingPage "1510" @default.
• W2005124425 abstract "Prostate cancer (CaP) is the most common cancer in adult men in North America. Since there is no naturally occurring prostate cancer in the mouse, preclinical studies stipulate for the establishment of a genetically manipulated mouse CaP model with features close to the human situation. In view of the limitations of transgenic technique-derived CaP models, herein we report the first application of knockin technology to establish a new mouse adenocarcinoma prostate model (PSP-KIMAP) by targeting of SV40 Tag to a prostate tissue-specific gene, PSP94 (prostate secretory protein of 94 amino acids). In order to demonstrate its novelty, we compared KIMAP to a PSP94 gene-directed transgenic mouse adenocarcinoma of the prostate (PSP-TGMAP) model. The CaP development of the PSP-KIMAP mice started almost immediately after puberty at 10 weeks of age from mouse prostatic intraepithelial neoplasia (mPIN) with microinvasion to well-differentiated CaP, and demonstrated a close-to-human kinetics of prolonged tumor growth and a predominance of well and moderately differentiated tumors. The invasive nature of KIMAP model was demonstrated by multitissue metastases (lymph node, lung and liver etc) and also by immunohistochemical study of multiple invasive prostate tumor markers. PSP-KIMAP model is responsive to androgen deprivation (castration). The knockin technology in our KIMAP model demonstrates highly predictive CaP development procedures and many advantageous features, which the traditional transgenic technique-derived CaP models could not reach for both basic and clinical studies. These features include the high stability of both phenotype and genotype, highly synchronous prostate cancer development, high and precise prostate tissue targeting and with no founder line variation. The differences between the two CaP models were attributed to the introduction of a single endogenous knockin mutation, resulting in a CaP model self-regulated and controlled by a prostate gene promoter/enhancer of PSP94." @default.
• W2005124425 created "2016-06-24" @default.
• W2005124425 creator A5004300259 @default.
• W2005124425 creator A5027524686 @default.
• W2005124425 creator A5037533913 @default.
• W2005124425 creator A5055091318 @default.
• W2005124425 creator A5062501400 @default.
• W2005124425 creator A5074252067 @default.
• W2005124425 creator A5079627883 @default.
• W2005124425 date "2005-01-17" @default.
• W2005124425 modified "2023-10-06" @default.
• W2005124425 title "Knockin of SV40 Tag oncogene in a mouse adenocarcinoma of the prostate model demonstrates advantageous features over the transgenic model" @default.
• W2005124425 cites W1502418486 @default.
• W2005124425 cites W1502422706 @default.
• W2005124425 cites W1857860166 @default.
• W2005124425 cites W1908134412 @default.
• W2005124425 cites W1980633528 @default.
• W2005124425 cites W1986559037 @default.
• W2005124425 cites W1988488966 @default.
• W2005124425 cites W1994834679 @default.
• W2005124425 cites W2005953810 @default.
• W2005124425 cites W2010013468 @default.
• W2005124425 cites W2010057554 @default.
• W2005124425 cites W2024349220 @default.
• W2005124425 cites W2037500272 @default.
• W2005124425 cites W2043806397 @default.
• W2005124425 cites W2046067408 @default.
• W2005124425 cites W2050041515 @default.
• W2005124425 cites W2052303857 @default.
• W2005124425 cites W2052327442 @default.
• W2005124425 cites W2060860221 @default.
• W2005124425 cites W2074279684 @default.
• W2005124425 cites W2081096345 @default.
• W2005124425 cites W2088522662 @default.
• W2005124425 cites W2093644958 @default.
• W2005124425 cites W2098588789 @default.
• W2005124425 cites W2113008095 @default.
• W2005124425 cites W2122675416 @default.
• W2005124425 cites W2124053736 @default.
• W2005124425 cites W2153549502 @default.
• W2005124425 cites W2324598527 @default.
• W2005124425 cites W4248667199 @default.
• W2005124425 doi "https://doi.org/10.1038/sj.onc.1208229" @default.
• W2005124425 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15674347" @default.
• W2005124425 hasPublicationYear "2005" @default.
• W2005124425 type Work @default.
• W2005124425 sameAs 2005124425 @default.
• W2005124425 citedByCount "35" @default.
• W2005124425 countsByYear W20051244252012 @default.
• W2005124425 countsByYear W20051244252013 @default.
• W2005124425 countsByYear W20051244252014 @default.
• W2005124425 countsByYear W20051244252015 @default.
• W2005124425 countsByYear W20051244252017 @default.
• W2005124425 countsByYear W20051244252021 @default.
• W2005124425 countsByYear W20051244252022 @default.
• W2005124425 crossrefType "journal-article" @default.
• W2005124425 hasAuthorship W2005124425A5004300259 @default.
• W2005124425 hasAuthorship W2005124425A5027524686 @default.
• W2005124425 hasAuthorship W2005124425A5037533913 @default.
• W2005124425 hasAuthorship W2005124425A5055091318 @default.
• W2005124425 hasAuthorship W2005124425A5062501400 @default.
• W2005124425 hasAuthorship W2005124425A5074252067 @default.
• W2005124425 hasAuthorship W2005124425A5079627883 @default.
• W2005124425 hasBestOaLocation W20051244251 @default.
• W2005124425 hasConcept C102230213 @default.
• W2005124425 hasConcept C104317684 @default.
• W2005124425 hasConcept C121608353 @default.
• W2005124425 hasConcept C141035611 @default.
• W2005124425 hasConcept C142724271 @default.
• W2005124425 hasConcept C2776235491 @default.
• W2005124425 hasConcept C2779534503 @default.
• W2005124425 hasConcept C2780192828 @default.
• W2005124425 hasConcept C2780940892 @default.
• W2005124425 hasConcept C2781182431 @default.
• W2005124425 hasConcept C502942594 @default.
• W2005124425 hasConcept C54355233 @default.
• W2005124425 hasConcept C71924100 @default.
• W2005124425 hasConcept C86803240 @default.
• W2005124425 hasConceptScore W2005124425C102230213 @default.
• W2005124425 hasConceptScore W2005124425C104317684 @default.
• W2005124425 hasConceptScore W2005124425C121608353 @default.
• W2005124425 hasConceptScore W2005124425C141035611 @default.
• W2005124425 hasConceptScore W2005124425C142724271 @default.
• W2005124425 hasConceptScore W2005124425C2776235491 @default.
• W2005124425 hasConceptScore W2005124425C2779534503 @default.
• W2005124425 hasConceptScore W2005124425C2780192828 @default.
• W2005124425 hasConceptScore W2005124425C2780940892 @default.
• W2005124425 hasConceptScore W2005124425C2781182431 @default.
• W2005124425 hasConceptScore W2005124425C502942594 @default.
• W2005124425 hasConceptScore W2005124425C54355233 @default.
• W2005124425 hasConceptScore W2005124425C71924100 @default.
• W2005124425 hasConceptScore W2005124425C86803240 @default.
• W2005124425 hasIssue "9" @default.
• W2005124425 hasLocation W20051244251 @default.
• W2005124425 hasLocation W20051244252 @default.
• W2005124425 hasOpenAccess W2005124425 @default.
• W2005124425 hasPrimaryLocation W20051244251 @default.
• W2005124425 hasRelatedWork W1536426327 @default.

• next